DSCR 5 Inhibitors
Chemical inhibitors of DSCR5 can interfere with various cellular processes that are essential for the protein's functional activity. Manumycin A, a farnesyltransferase inhibitor, disrupts the post-translational modification of proteins that undergo farnesylation, a process that could be crucial for the proper functioning of DSCR5. Similarly, GGTI-298 blocks the geranylgeranylation of proteins. This inhibition of lipid modifications can prevent the association of proteins with cell membranes, which is a necessary step for DSCR5 to carry out its role in GPI-anchor biosynthesis. Decylubiquinone, as a mimic of coenzyme Q10, disrupts the mitochondrial electron transport chain, altering the cellular energy state and potentially the signaling pathways that DSCR5 relies on. Furthermore, Tunicamycin's inhibition of N-linked glycosylation, while not directly affecting GPI-anchor biosynthesis, can indirectly affect the cellular milieu necessary for DSCR5's activity.
Other inhibitors affect the localization and environment of DSCR5 within the cell membrane. Brefeldin A inhibits protein trafficking, which can prevent DSCR5 from reaching the cell membrane where it exerts its function. Filipin, which binds to cholesterol, disrupts lipid raft domains, potentially displacing DSCR5 from these specialized membrane areas that are critical for its signaling functions. Lovastatin, by inhibiting cholesterol synthesis, can similarly affect the membrane localization of DSCR5. Cytochalasin D, which disrupts actin polymerization, affects not just the overall cell morphology but also the cytoskeletal structures that are important for the trafficking and positioning of DSCR5. Other chemical inhibitors, such as Itraconazole, Perphenazine, Genistein, and Progesterone, act through different mechanisms but ultimately influence the cellular signaling environment of DSCR5. Itraconazole disrupts the Hedgehog signaling pathway; Perphenazine inhibits calmodulin, a key player in signal transduction; Genistein inhibits tyrosine kinases, which can affect phosphorylation-dependent signaling processes; and Progesterone modulates gene expression profiles, which can alter the functional context in which DSCR5 operates. Each of these inhibitors, through their unique modes of action, can disrupt the functional activities of DSCR5.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Manumycin A | 52665-74-4 | sc-200857 sc-200857A | 1 mg 5 mg | $219.00 $634.00 | 5 | |
Manumycin A is a farnesyltransferase inhibitor; it inhibits the post-translational modification of proteins that undergo farnesylation. As DSCR5 is involved in GPI-anchor biosynthesis, the inhibition of farnesyltransferase can lead to reduced functionality of GPI-anchored proteins, potentially inhibiting DSCR5 by disrupting the proteins that interact with or are modified by it. | ||||||
Itraconazole | 84625-61-6 | sc-205724 sc-205724A | 50 mg 100 mg | $78.00 $142.00 | 23 | |
Itraconazole, an antifungal agent, has been shown to inhibit Hedgehog signaling pathway. Since GPI-anchored proteins are implicated in the modulation of this pathway, the inhibition of Hedgehog signaling could disrupt the functional interactions of DSCR5 with its partners, leading to its functional inhibition. | ||||||
GGTI 298 | 1217457-86-7 | sc-361184 sc-361184A | 1 mg 5 mg | $193.00 $838.00 | 2 | |
GGTI-298 is a geranylgeranyltransferase inhibitor, which blocks the geranylgeranylation of proteins. Similar to farnesyltransferase inhibition, blocking this post-translational modification affects the membrane anchoring and function of certain proteins, potentially disrupting processes or interactions necessary for DSCR5 function. | ||||||
Perphenazine | 58-39-9 | sc-208161 | 100 mg | $190.00 | ||
Perphenazine, an antipsychotic drug, has been found to inhibit calmodulin. As calmodulin is involved in a multitude of cellular processes, including signal transduction pathways, its inhibition can affect the cellular environment and signaling context in which DSCR5 operates, leading to its functional inhibition. | ||||||
Decylubiquinone | 55486-00-5 | sc-358659 sc-358659A | 10 mg 50 mg | $70.00 $269.00 | 10 | |
Decylubiquinone is an analogue of coenzyme Q10 and acts as an inhibitor of mitochondrial electron transport chain. Since GPI-anchored proteins like DSCR5 are involved in cellular signaling, disrupting the mitochondrial function can alter the cellular energy state and signaling pathways, potentially leading to the functional inhibition of DSCR5. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation. While DSCR5 is involved in GPI-anchor biosynthesis, which is distinct from N-linked glycosylation, the inhibition of overall glycosylation processes can indirectly disturb the cellular pathways and environment that DSCR5 requires for its function, leading to its inhibition. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts protein trafficking by inhibiting ADP-ribosylation factor. GPI-anchored proteins, such as DSCR5, rely on proper trafficking to the cell membrane to function. By disrupting this trafficking, Brefeldin A can inhibit the proper localization and function of DSCR5. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor, and while DSCR5 is not a kinase, the phosphorylation state of proteins can affect GPI-anchored protein function. Therefore, tyrosine kinase inhibition can disrupt signaling pathways necessary for the proper function of DSCR5, leading to its inhibition. | ||||||
Filipin III | 480-49-9 | sc-205323 sc-205323A | 500 µg 1 mg | $118.00 $148.00 | 26 | |
Filipin binds to cholesterol in the cell membrane, disrupting lipid raft domains. Since GPI-anchored proteins like DSCR5 are often localized within these domains for proper signaling, disrupting lipid rafts with Filipin can inhibit the functional activity of DSCR5. | ||||||
Progesterone | 57-83-0 | sc-296138A sc-296138 sc-296138B | 1 g 5 g 50 g | $20.00 $52.00 $298.00 | 3 | |
Progesterone, through its receptor-mediated action, can alter gene expression profiles and cellular processes. This hormonal signaling can influence the cell's signaling environment in which DSCR5 operates, potentially leading to the functional inhibition of DSCR5 through altered cell signaling dynamics. | ||||||